252 related articles for article (PubMed ID: 31126898)
1. Peak OGTT glucose is associated with lower lung function in young children with cystic fibrosis.
Prentice BJ; Chelliah A; Ooi CY; Hameed S; Verge CF; Plush L; Widger J
J Cyst Fibros; 2020 Mar; 19(2):305-309. PubMed ID: 31126898
[TBL] [Abstract][Full Text] [Related]
2. Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.
Taylor-Cousar JL; Janssen JS; Wilson A; Clair CG; Pickard KM; Jones MC; Brayshaw SJ; Chacon CS; Barboa CM; Sontag MK; Accurso FJ; Nichols DP; Saavedra MT; Nick JA
J Diabetes Res; 2016; 2016():1527932. PubMed ID: 27999822
[No Abstract] [Full Text] [Related]
3. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
[TBL] [Abstract][Full Text] [Related]
4. Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients.
Leclercq A; Gauthier B; Rosner V; Weiss L; Moreau F; Constantinescu AA; Kessler R; Kessler L
J Cyst Fibros; 2014 Jul; 13(4):478-84. PubMed ID: 24359972
[TBL] [Abstract][Full Text] [Related]
5. Abnormal glucose tolerance and lung function in children with cystic fibrosis. Comparing oral glucose tolerance test and continuous glucose monitoring.
Elidottir H; Diemer S; Eklund E; Hansen CR
J Cyst Fibros; 2021 Sep; 20(5):779-784. PubMed ID: 33478894
[TBL] [Abstract][Full Text] [Related]
6. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
Scully KJ; Brenner L; Martin K; Ruazol M; Sawicki GS; Uluer A; Neuringer I; Yonker LM; Sicilian L; Putman MS
Front Endocrinol (Lausanne); 2024; 15():1293709. PubMed ID: 38379863
[TBL] [Abstract][Full Text] [Related]
7. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
[TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis.
Chan CL; Pyle L; Vigers T; Zeitler PS; Nadeau KJ
J Clin Endocrinol Metab; 2022 Jan; 107(2):e548-e560. PubMed ID: 34537845
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemia is common in children with cystic fibrosis and seen predominantly in females.
Haliloglu B; Gokdemir Y; Atay Z; Abali S; Guran T; Karakoc F; Ersu R; Karadag B; Turan S; Bereket A
Pediatr Diabetes; 2017 Nov; 18(7):607-613. PubMed ID: 27873431
[TBL] [Abstract][Full Text] [Related]
11. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
Coriati A; Ziai S; Lavoie A; Berthiaume Y; Rabasa-Lhoret R
Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
[TBL] [Abstract][Full Text] [Related]
12. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
[TBL] [Abstract][Full Text] [Related]
13. Can continuous glucose monitoring predict cystic fibrosis-related diabetes and worse clinical outcome?
Zorron M; Marson FAL; Morcillo AM; Gonçalves AC; El Beck MS; Ribeiro JD; Ribeiro AF
J Bras Pneumol; 2022; 48(2):e20210307. PubMed ID: 35475864
[TBL] [Abstract][Full Text] [Related]
14. Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
Rakotoarisoa L; Weiss L; Lefebvre F; Porzio M; Renaud-Picard B; Ravoninjatovo B; Abely M; Danner-Boucher I; Dubois S; Troussier F; Prevotat A; Rault G; Kessler R; Kessler L
J Diabetes Complications; 2024 Apr; 38(4):108703. PubMed ID: 38430625
[TBL] [Abstract][Full Text] [Related]
15. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
[TBL] [Abstract][Full Text] [Related]
16. Continuous glucose monitoring guided insulin therapy is associated with improved clinical outcomes in cystic fibrosis-related diabetes.
Frost F; Dyce P; Nazareth D; Malone V; Walshaw MJ
J Cyst Fibros; 2018 Nov; 17(6):798-803. PubMed ID: 29885744
[TBL] [Abstract][Full Text] [Related]
17. MARKEDLY DELAYED INSULIN SECRETION AND A HIGH RATE OF UNDETECTED OVERT DIABETES CHARACTERIZE GLUCOSE METABOLISM IN ADULT PATIENTS WITH CYSTIC FIBROSIS AFTER LUNG TRANSPLANTATION.
Winhofer Y; Wolf P; Fellinger P; Tura A; Hillebrand P; Staufer K; Trauner M; Jaksch P; Muraközy G; Kautzky-Willer A; Pacini G; Krebs M; Luger A; Kazemi-Shirazi L
Endocr Pract; 2019 Mar; 25(3):254-262. PubMed ID: 30913015
[TBL] [Abstract][Full Text] [Related]
18. Abnormal glucose tolerance in children with cystic fibrosis: the predictive role of continuous glucose monitoring system.
Schiaffini R; Brufani C; Russo B; Fintini D; Migliaccio A; Pecorelli L; Bizzarri C; Lucidi V; Cappa M
Eur J Endocrinol; 2010 Apr; 162(4):705-10. PubMed ID: 20071479
[TBL] [Abstract][Full Text] [Related]
19. Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET).
Coriati A; Ziai S; Azar M; Berthiaume Y; Rabasa-Lhoret R
J Cyst Fibros; 2016 Jan; 15(1):127-32. PubMed ID: 25818059
[TBL] [Abstract][Full Text] [Related]
20. Delayed glucose peak and elevated 1-hour glucose on the oral glucose tolerance test identify youth with cystic fibrosis with lower oral disposition index.
Tommerdahl KL; Brinton JT; Vigers T; Cree-Green M; Zeitler PS; Nadeau KJ; Chan CL
J Cyst Fibros; 2021 Mar; 20(2):339-345. PubMed ID: 32928701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
